Distinguished in Developmental Dysphasia Familial

Frank Jessen

Kerpener Str 62, 
Koeln, NW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Developmental Dysphasia Familial
Kerpener Str 62, 
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Frank Jessen practices in Koeln, Germany. Mr. Jessen is rated as a Distinguished expert by MediFind in the treatment of Developmental Dysphasia Familial. His top areas of expertise are Dementia, Alzheimer's Disease, Memory Loss, Developmental Dysphasia Familial, and Deep Brain Stimulation.

His clinical research consists of co-authoring 456 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 44 articles in the study of Developmental Dysphasia Familial.

Gender
Male

Locations

Kerpener Str 62, Koeln, NW 50937, Germany
Other Locations
Kerpener Str. 68, Koeln, NW 50937, Germany
Ludwig Erhard Allee 2, Bonn, NW 53175, Germany
Sigmund Freud Str. 25, Bonn, NW 53127, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol Vs. Placebo As an Add-on to an Individualized Antipsychotic Treatment
Enhancing Recovery in Early Schizophrenia - a Multi-center, Two-arm, Double-blind, Randomized Phase II Trial Investigating Cannabidiol Vs. Placebo As an Add-on to an Individualized Antipsychotic Treatment
Enrollment Status: Recruiting
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drug: Cannabidiol as Add-On
Study Phase: Phase 2
A Multicenter Randomized Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline
A Multicenter Randomized Superiority Study To Compare The Effects Of An 8-Weeks Mindfulness-based Intervention Versus Health Education Programme On Mental Health And Wellbeing In Individuals With Subjective Cognitive Decline
Enrollment Status: Completed
Publish Date: February 20, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A 24 Months Randomised, Placebo-controlled, Parallel Group, Double Blinded, Multi Centre, Phase 2 Study to Assess Safety and Efficacy of AADvac1 Applied to Patients With Mild Alzheimer's Disease
A 24 Months Randomised, Placebo-controlled, Parallel Group, Double Blinded, Multi Centre, Phase 2 Study to Assess Safety and Efficacy of AADvac1 Applied to Patients With Mild Alzheimer's Disease
Enrollment Status: Completed
Publish Date: November 14, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 2
View 3 Less Clinical Trials

450 Total Publications

The effect of psychotherapy on the multivariate association between insomnia and depressive symptoms in late-life depression.
The effect of psychotherapy on the multivariate association between insomnia and depressive symptoms in late-life depression.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jessen's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile